All4NutraNo products in the cart.
All4NutraStartseite » Poloxamer » Page 3
This study explores the role of 2-hydroxypropyl-β-cyclodextrin (HPβCD) as an excipient in liquid formulations by evaluating its physical properties, thermal...
Abstract Lipid-based drug delivery carriers have exhibited substantial potential for promoting wound healing. Here, Phospholipon® 90H (P90H) based lipid nanoparticles...
Abstract The limited aqueous solubility of numerous active pharmaceutical ingredients (APIs) remains a major barrier to achieving optimal oral bioavailability,...
Abstract Topical dosage forms represent a critical segment of pharmaceutical products, offering localized drug delivery with minimal systemic exposure. This...
Abstract Cancer remains to be one of the most life-threatening diseases with high rates of mortality and morbidity. The major...
PRESS RELEASE 19. November 2025 - Croda International Plc (“Croda”), a global leader in specialty ingredients, today announced a strategic...
Abstract Formulation development of protein biopharmaceuticals has become increasingly challenging due to new modalities and higher target drug substance concentrations....
Abstract The liquid and solid formulations of self-nano-emulsifying drug delivery systems (SNEDDS) have garnered significant attention in the pharmaceutical field...
Abstract Background: Solid dispersions (SDs) of etodolac (ETD), a poorly water-soluble drug model, were developed to enhance its solubility and dissolution...
Abstract Tacrolimus (TAC), a calcineurin inhibitor used topically for T-cell-mediated skin diseases, faces challenges due to poor solubility and limited...
Copyright: PharmaExcipients AG